Font Size: a A A

Yunnan Baiyao's Financial Statements Analysis

Posted on:2018-07-01Degree:MasterType:Thesis
Country:ChinaCandidate:B D HongFull Text:PDF
GTID:2359330512495810Subject:Business management
Abstract/Summary:PDF Full Text Request
Although Pharmaceutical health industry subject to the vague growth of the economic and the low growth rate of environmental impact,the industry makes full use of its own inherent resistance to the economic cyclical risks of power.Along with an increasing enhancement of population and human consciousness of self health care,the industry still maintain a steady growth in global pharmaceutical market and health industry has become the most promising sunrise industry.During the period of“13 Five-Year" project,China will promote the healthy construction,deepening medical and health system reform,rationalizing drug prices and the implementation of health care,medical linkage and establishing the basic medical and health system covering urban and rural areas and the modern hospital management system.With the improvement of people's living standard,people pay more attention to health care and medical health in China will better help the pharmaceutical industry transformation to meet the people's needs.At the same time,population aging and the aging of the sick rate is higher,the government continue to regulate the pharmaceutical industry and increase and guide capital investment,under these factors the pharmaceutical industry become one of China's fastest growing industry over the years.As a member of the pharmaceutical industry,Yunnan Baiyao Group Co.,Ltd.(hereinafter referred to as "Yunnan Baiyao")is under the strategy of the "new Baiyao,a large health" and work as a guide,focus on personal health demand,grasp the rule of no disease for the orientation of the future market opportunities,which is committed to create medicine of the whole industry chain,business covers resources of traditional Chinese medicine,western medicine materials,preparation,personal care products,native herbs,commercial circulation.The focus of the big health industry is China's pharmaceutical market in recent years,one of the fastest growing segments of the market,and the market development space is broad.This paper chooses Yunnan Baiyao as the research object,citing Harvard Analysis Framework of Yunnan Baiyao industry background and development strategy analysis.In combination with the company's financial statements from 2010 to 2014 years and related data to project accounting policy and make analysis and evaluation on the basis,from the cash flow,profit ability,operation ability,debt paying ability and the ability to grow dimensions of Yunnan Baiyao of financial analysis,and finally a comprehensive strategy,accounting and financial aspects of analysis results,the prospects of the development of Yunnan Baiyao estimate,pointing out the strategic measures of shortages and gives the corresponding risk response and suggestions on how to solve problems.This paper hopes to support the long-term development of Yunnan Baiyao,also hope that other enterprises can learn from it.In this paper,we study that Yunnan Baiyao subdivision market is full of opportunities for development,the company's development strategy is also clear and pragmatic,but in the process of implementation of the strategy emphasis on short-term seeking scale and ignore the long-term development of the company's sustainability.It is suggested that the company make appropriate adjustments in time to avoid the future development of stagnant or even reverse the risk.
Keywords/Search Tags:Yunnan Baiyao, development strategy, the Harvard framework, financial analysis
PDF Full Text Request
Related items